If a patient has a stage 2 pressure injury (pressure ulcer) and develops purple discoloration with epithelial tissue present, should it be reclassified as a deep tissue injury (DTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Reclassification of Stage 2 Pressure Injury with Purple Discoloration

Yes, a stage 2 pressure injury that develops purple discoloration should be reclassified as a deep tissue injury (DTI), even if epithelial tissue is present. 1

Understanding Deep Tissue Injury vs. Stage 2 Pressure Injury

  • A stage 2 pressure injury involves partial-thickness skin loss with exposed dermis, while a deep tissue injury (DTI) indicates damage to underlying tissues that may not be immediately visible at the skin surface 1
  • Purple discoloration is a hallmark sign of DTI, indicating damage to deeper tissues even when the epidermis appears intact or healing 1, 2
  • The presence of epithelial tissue with purple discoloration suggests a mixed presentation where superficial healing may be occurring while deeper tissue damage is present 3

Diagnostic Criteria for Deep Tissue Injury

  • The primary visual indicator of DTI in light-skinned patients is purple or maroon discoloration with a defined border, often with surrounding erythema 1
  • Purple discoloration represents blood and fluid from damaged blood vessels in the deeper tissues, which is pathognomonic for DTI 4
  • Even with epithelialization occurring, the purple discoloration indicates ongoing deep tissue damage that requires different management than a simple stage 2 injury 2

Evolution and Progression of Deep Tissue Injuries

  • DTIs often evolve rapidly despite appropriate preventive interventions, with 9.3% deteriorating to full-thickness tissue loss even with standard care 3
  • The purple discoloration may precede rapid deterioration as damaged muscle tissue stiffens and abnormally deforms adjacent tissues 5
  • DTIs can remain "invisible" for up to 48 hours before manifesting visible signs, making early recognition of any purple discoloration critically important 2

Management Implications

  • Reclassifying as DTI changes the management approach, requiring more aggressive pressure redistribution and more frequent assessment 4
  • DTIs require more vigilant monitoring as they can rapidly deteriorate despite appropriate interventions 3
  • The presence of epithelial tissue should not provide false reassurance when purple discoloration is present, as the deeper damage may continue to evolve 1, 2

Differential Diagnosis Considerations

  • Other conditions can present with purple discoloration and should be ruled out, including bruising, hematoma, venous engorgement, and arterial insufficiency 1
  • A thorough history to account for pressure exposure is essential for accurate diagnosis of DTI 1, 2
  • The combination of previously documented stage 2 injury with new purple discoloration strongly supports reclassification as DTI rather than these alternative diagnoses 1

Documentation and Monitoring

  • When reclassifying the injury, document the change in appearance, specifically noting the purple discoloration and any other changes in the wound bed 4
  • Implement more frequent assessments (at least daily) to monitor for rapid deterioration that may occur with DTIs 3, 2
  • Document the size, depth, and characteristics of the wound to track progression and response to interventions 4

By correctly reclassifying the pressure injury as a DTI when purple discoloration appears, you ensure appropriate care planning and interventions that address the deeper tissue damage, potentially preventing further deterioration and improving outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.